Novartis, an innovative healthcare products company with pharmaceutical treatments for heart disease, high blood pressure, diabetes, parkinsons, alzheimers, infectious disease and cancer.

worldwide offices | stay connected | contact | help | site map | large text version regular text version

Employee Wellness Programme

Media releases

February 17, 2012
Novartis to revise product information in the European Union for high blood pressure drug Rasilez® following assessment by CHMP

February 13, 2012
FDA requests additional data on Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for expanded use in infants and toddlers

February 07, 2012
Pivotal study published in JAMA confirms potential of Novartis candidate vaccine Bexsero® to help protect infants against devastating meningococcal serogroup B disease

View all press releases

Feature story ›

April 25 is World Malaria Day, an opportunity to reflect on the progress made in finding sustainable solutions for malaria. More ›

Latest Annual reports ›

Download PDF 2008 (3,4 MB)

Download PDF 2007 (3,7 MB)

View all

Novartis in the news ›

World Hypertention Day: 17th May 2010 More ›

View all

Industry news ›

Sandoz receives positive EU opinion for biosimilar filgrastim. More ›

View all